Erratum: Secondary prevention for patients after a myocardial infarction: Summary of NICE guidance (BMJ (Online) (2007) 334 (1112) DOI: 10.1136/bmj.39204.531586.AD);Secondary prevention for patients after a myocardial infarction: Summary of NICE guidance

British Medical Journal

Volumn 334, Issue 7603, 2007, Pages 1112-1113

  Skinner, J S ^a   Cooper, A ^b   Feder, G S ^c  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

COGNITIVE THERAPY; COMORBIDITY; DIET THERAPY; DRUG EFFICACY; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEART FAILURE; HEART INFARCTION; HEART REHABILITATION; HUMAN; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MORTALITY; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SMOKING CESSATION; STRESS MANAGEMENT; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; CONGESTIVE HEART FAILURE; LIFESTYLE; PATIENT REFERRAL; REVIEW;

HEART FAILURE, CONGESTIVE; HUMANS; LIFE STYLE; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION;

EID: 34249791201     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f6923     Document Type: Erratum

References (9)

1. Royal College of Physicians. Myocardial infarction national audit project (MINAP). www.rcplondon.ac.uk/college/ceeu/ceeu_ami_ home.htm.
2. Bethell HJ, Turner SC, Evans JA, Rose L. Cardiac rehabilitation in the United Kingdom: how complete is the provision? J Cardiopulm Rehabil 2001;21:111-5.
3. National Institute for Health and Clinical Excellence. Clinical guideline 48: MI: secondary prevention in primary and secondary care for patients following a myocardial infarction. London: NICE, 2007. www.nice.org.uk/CG48
4. National Institute for Clinical Excellence. TA039: smoking cessation - bupropion and nicotine replacement therapy. London: NICE, 2002. www.nice.org.uk/TA39
5. National Institute for Health and Clinical Excellence. PHI001: smoking cessation - brief interventions and referral for smoking cessation in primary care and other settings. London: NICE, 2006. http://guidance.nice.org.uk/ PHI1
6. National Institute for Health and Clinical Excellence. Clinical guideline 43: obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. London: NICE, 2006. www.nice.org.uk/CG43
7. University of York. Cardiac rehabilitation. BHF Cardiac Cardiac Care and Education Research Group. www.cardiacrehabilitation.org.uk/heart_manual/ heartmanual.htm
8. National Institute for Clinical Excellence. TAO80: acute coronary syndromes - clopidogrel. London: NICE, 2004. www.nice.org.uk/TA80
9. National Institute for Health and Clinical Excellence. TA095: arrhythmia - implantable cardioverter defibrillators (ICDs) (review). London: NICE, 2006.www.nice.org.uk/TA95